Minardi, M.L.; Fato, I.; Di Gennaro, F.; Mosti, S.; Mastrobattista, A.; Cerva, C.; Libertone, R.; Saracino, A.; Goletti, D.; Girardi, E.;
et al. Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art. Microorganisms 2021, 9, 1477.
https://doi.org/10.3390/microorganisms9071477
AMA Style
Minardi ML, Fato I, Di Gennaro F, Mosti S, Mastrobattista A, Cerva C, Libertone R, Saracino A, Goletti D, Girardi E,
et al. Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art. Microorganisms. 2021; 9(7):1477.
https://doi.org/10.3390/microorganisms9071477
Chicago/Turabian Style
Minardi, Maria Letizia, Ilenia Fato, Francesco Di Gennaro, Silvia Mosti, Annelisa Mastrobattista, Carlotta Cerva, Raffaella Libertone, Annalisa Saracino, Delia Goletti, Enrico Girardi,
and et al. 2021. "Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art" Microorganisms 9, no. 7: 1477.
https://doi.org/10.3390/microorganisms9071477
APA Style
Minardi, M. L., Fato, I., Di Gennaro, F., Mosti, S., Mastrobattista, A., Cerva, C., Libertone, R., Saracino, A., Goletti, D., Girardi, E., Andreoni, M., Palmieri, F., & Gualano, G.
(2021). Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art. Microorganisms, 9(7), 1477.
https://doi.org/10.3390/microorganisms9071477
